Cost-effectiveness in primary prevention, cost savings in secondary prevention: Promoting therapy adherence to antilipemic agents is cost effective: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie

Stefan Vegter, Piter Oosterhof, Job F. M. Van Boven, Ada G. G. Stuurman-Bieze, Eric Hiddink, Maarten J. Postma

Research output: Contribution to journalArticleProfessional

Translated title of the contributionCost-effectiveness in primary prevention, cost savings in secondary prevention: Promoting therapy adherence to antilipemic agents is cost effective
Original languageDutch
Pages (from-to)30-31
Number of pages2
JournalPharmaceutisch Weekblad
Volume149
Issue number35
Publication statusPublished - 29-Aug-2014

Keywords

  • antilipemic agent
  • cost control
  • cost effectiveness analysis
  • human
  • patient compliance
  • primary prevention
  • secondary prevention
  • short survey

Cite this